14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.720 Wednesday, 24th Apr 2024 ADXS stock ended at $0.540. During the day the stock fluctuated 0% from a day low at $0.540 to a day high of $0.540.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Oct 24, 2023 $0.85 $0.86 $0.80 $0.81 3 263
Oct 23, 2023 $0.90 $0.95 $0.88 $0.90 7 228
Oct 20, 2023 $0.90 $0.90 $0.90 $0.90 2 633
Oct 19, 2023 $0.90 $0.90 $0.90 $0.90 334
Oct 18, 2023 $0.93 $0.93 $0.93 $0.93 218
Oct 17, 2023 $0.91 $0.95 $0.91 $0.91 1 626
Oct 16, 2023 $0.96 $0.96 $0.91 $0.91 1 213
Oct 13, 2023 $0.93 $0.93 $0.93 $0.93 162
Oct 12, 2023 $0.94 $1.00 $0.94 $1.00 595
Oct 11, 2023 $0.92 $0.95 $0.91 $0.95 4 776
Oct 10, 2023 $0.91 $1.00 $0.91 $1.00 2 451
Oct 09, 2023 $0.95 $1.06 $0.91 $1.04 1 161
Oct 06, 2023 $0.91 $1.15 $0.91 $1.01 8 339
Oct 05, 2023 $0.90 $0.90 $0.90 $0.90 152
Oct 04, 2023 $1.06 $1.06 $0.95 $1.05 6 662
Oct 03, 2023 $0.98 $1.09 $0.82 $1.06 5 656
Oct 02, 2023 $0.94 $0.99 $0.91 $0.99 3 629
Sep 29, 2023 $0.790 $1.00 $0.790 $0.94 5 211
Sep 28, 2023 $0.89 $0.92 $0.80 $0.80 5 520
Sep 27, 2023 $0.88 $0.89 $0.88 $0.89 1 634
Sep 26, 2023 $0.89 $0.89 $0.89 $0.89 253
Sep 25, 2023 $0.89 $0.89 $0.89 $0.89 0
Sep 22, 2023 $0.89 $0.89 $0.89 $0.89 335
Sep 21, 2023 $0.89 $0.89 $0.89 $0.89 119
Sep 20, 2023 $0.91 $0.95 $0.90 $0.95 3 821
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT